“The probability of a near-term equity raise depends on how the share price responds to FDA approval in CD and to the 2Q23 financial results.”
Speaking of probabilities, one of the reasons I invested in RVNC was the notion they would be eventually bought out at a market capitalization of $4-5 Billion after the FDA granted approval for the medical treatment of CD and a pathway to profitability.
Do you (and others here) still believe this is viable opportunity for the company to be purchased outright? TIA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.